MICHAEL KAVUR: Open Payments
NPI 1891140919 · ESTILL SPRINGS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,506 in 115 payments from 11 companies in 2025. Trend: 2023 $1,248 · 2024 $1,310 · 2025 $41,506
Speaker / faculty: $36,246Food & beverage: $2,390Travel & lodging: $2,301Consulting: $460Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 51 | $40,046 |
| Neurocrine BioSciences, Inc. | 14 | $423 |
| Vanda Pharmaceuticals Inc. | 9 | $211 |
| Alkermes, Inc. | 8 | $179 |
| E.R. Squibb & Sons, L.L.C. | 8 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $146 |
| ABBVIE INC. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
Products named: AUSTEDO XR, INGREZZA, FANAPT, COBENFY, CAPLYTA, VRAYLAR, ARISTADA, LYBALVI.
Industry payments across TN — which companies pay providers there.
